Decitabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Decitabine.
Product ID | 69097-905_b1c56b73-f0bc-403f-85a2-c73de0c43bc5 |
NDC | 69097-905 |
Product Type | Human Prescription Drug |
Proprietary Name | Decitabine |
Generic Name | Decitabine |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-09-17 |
Marketing Category | ANDA / |
Application Number | ANDA205539 |
Labeler Name | Cipla USA Inc. |
Substance Name | DECITABINE |
Active Ingredient Strength | 50 mg/10mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-09-17 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9385 | decitabine | decitabine |
0781-3139 | Decitabine | Decitabine |
0781-3296 | Decitabine | Decitabine |
16714-749 | Decitabine | Decitabine |
16714-928 | Decitabine | Decitabine |
16729-224 | Decitabine | decitabine |
25021-231 | decitabine | decitabine |
42737-110 | Decitabine | Decitabine |
43598-348 | Decitabine | Decitabine |
43598-427 | Decitabine | Decitabine |
47335-361 | decitabine | decitabine |
50742-430 | DECITABINE | decitabine |
55111-556 | Decitabine | Decitabine |
55150-376 | Decitabine | Decitabine |
68001-347 | Decitabine | Decitabine |
69097-285 | Decitabine | Decitabine |
67457-316 | Decitabine | Decitabine |
64679-067 | Decitabine | Decitabine |
68001-422 | Decitabine | Decitabine |
69539-115 | Decitabine | Decitabine |
63323-825 | Decitabine | Decitabine |
68180-738 | decitabine | decitabine |
70121-1644 | Decitabine | Decitabine |
72205-031 | Decitabine | Decitabine |
72205-036 | Decitabine | Decitabine |
75834-190 | DECITABINE | DECITABINE |
72603-107 | Decitabine | Decitabine |
59148-046 | Dacogen | decitabine |